Dr. Paul J Ceplenski, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Lake St, New Britain, CT 06052 Phone: 860-826-4453 Fax: 860-224-6260 |
Dr. Corlis L. Archer-goode, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Lake St, Bldg B2nd, New Britain, CT 06052 Phone: 860-826-4453 Fax: 860-826-6219 |
Dr. Robert Aj Ave'lallemant, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Lake St, Grove Hill Medical Center, New Britain, CT 06052 Phone: 860-826-4453 Fax: 860-826-6219 |
Dr. Joshua Aaron Stein, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Lake St, #b, New Britain, CT 06052 Phone: 860-826-4453 |
Dr. Keith A Kaplan, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Lake St, New Britain, CT 06052 Phone: 860-826-4453 Fax: 860-826-6219 |
News Archive
Seventh Sense Biosystems announced today that it has received a Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Dr. Howard Bernstein, titled "On-skin and Intra-dermal Malaria Diagnostics with Unprecedented Simplicity of Use Based on Bio-Responsive Particles and Interstitial Fluid Analysis."
Patients are being put at risk because some hospital doctors are not always following warning procedures over known drug allergies, new research launched at the British Pharmaceutical Conference (BPC) in Manchester shows.
A case-control study of more than 2000 people has identified a number of factors that may induce primary biliary cirrhosis (PBC) in genetically susceptible individuals. These include a history of urinary tract infections, hormone replacement therapy, tobacco use, and nail polish use.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented efficacy, safety and biodistribution results on its new biotherapy AMEP™ for advanced and metastatic melanoma at the 13th Annual Meeting of the American Society of Gene and Cell Therapy in Washington, DC (May 17 - 22, 2010).
Pavilion Financial Corporation, an employee-owned, diversified global investment services firm, today announced the acquisition of the business of Plan Sponsor Advisors, an investment and retirement benefit consulting firm specializing in defined contribution plans. The transaction is expected to close on or around June 20th.
› Verified 9 days ago